MUC1 and familial pancreatic carcinoma: showed that altering MUC1 epitope structures significantly increases the immunogenicity of pancreatic cancer, stimulating more cytotoxic T cells (CTLs), and indicating potential in enhancing pancreatic cancer immunotherapy (127).